Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7

References

• Perlikos F, Harrington KJ, Syrigos KN. Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol. 2013;87:1.
   PubMed Web of Science ®Google Scholar
• Politi K, Herbst RS. Lung cancer in the era of precision medicine. Clin Cancer Res. 2015;21:2213.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446.
   PubMed Web of Science ®Google Scholar
• Zeng B, Ji P, Chen C, et al. A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer. Int J Biochem Cell Biol. 2020;127:105825.
   PubMed Web of Science ®Google Scholar
• Silva GT, Bergmann A, Thuler LC. Incidence, associated factors, and survival in metastatic spinal cord compression secondary to lung cancer. Spine J. 2015;15:1263.
   PubMed Web of Science ®Google Scholar
• Biddle A, Mackenzie IC. Cancer stem cells and EMT in carcinoma. Cancer Metastasis Rev. 2012;31:285–293.
   PubMed Web of Science ®Google Scholar
• Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178.
   PubMed Web of Science ®Google Scholar
• Bill R, Christofori G. The relevance of EMT in breast cancer metastasis: correlation or causality? FEBS Lett. 2015;589:1577.
   PubMed Web of Science ®Google Scholar
• Mak MP, Tong P, Diao L, et al. A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition. Clin Cancer Res. 2016;22:609.
   PubMed Web of Science ®Google Scholar
• Lin CW, Liao MY, Lin WW, et al. Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer. J Biol Chem. 2012;287:39449.
   PubMed Web of Science ®Google Scholar
• Shu J, Wang L, Han F, et al. BTBD7 downregulates E-Cadherin and promotes epithelial-mesenchymal transition in lung cancer. Biomed Res Int. 2019;5937635:2019.
   Google Scholar
• Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer. 2011;30:603.
   PubMedGoogle Scholar
• Kim SH, Kim JM, Shin MH, et al. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung. Histol Histopathol. 2012;27:581.
   PubMed Web of Science ®Google Scholar
• Sun X, Yan P, Zou C, et al. Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives. Med Res Rev. 2019;39:2172.
   PubMed Web of Science ®Google Scholar
• White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang CJ, Chia WN, et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun. 2015;6:10111.
   PubMed Web of Science ®Google Scholar
• Shi R, Cui H, Bi Y, et al. Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma. Oncol Lett. 2015;9:2249.
   PubMed Web of Science ®Google Scholar
• Saunders WS, Shuster M, Huang X, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A. 2000;97:303.
   PubMed Web of Science ®Google Scholar
• Chen Q, Lu X, Liu Q, et al. SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma. World J Surg Oncol. 2018;16:32.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang T, Zhang J, et al. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis. Cancer Biomark. 2016;17:179.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang T, Zhang J, et al. BTBD7 silencing inhibited epithelial-mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma. Cancer Biomark. 2017;20:461.
   PubMed Web of Science ®Google Scholar
• Tao YM, Huang JL, Zeng S, et al. BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma. Hepatology. 2013;57:2326.
   PubMed Web of Science ®Google Scholar
• Woodward RM, Brown ML, Stewart ST, et al. The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF. Cancer. 2007;110:2511.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277.
   PubMed Web of Science ®Google Scholar
• Wu Y, Liu HB, Ding M, et al. The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis. Mol Biol Rep. 2012;39:9621.
   PubMed Web of Science ®Google Scholar
• Hui L, Zhang S, Dong X, et al. Prognostic significance of twist and N-cadherin expression in NSCLC. PLoS One. 2013;8:e62171.
   PubMed Web of Science ®Google Scholar
• Nagathihalli NS, Massion PP, Gonzalez AL, et al. Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin. Mol Cancer Ther. 2012;11:2362.
   PubMed Web of Science ®Google Scholar
• Kim WY, Perera S, Zhou B, et al. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest. 2009;119:2160.
   PubMed Web of Science ®Google Scholar
• Kasai H, Allen JT, Mason RM, et al. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res. 2005;6:56.
   PubMed Web of Science ®Google Scholar
• Rieber M, Strasberg RM. DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin. Int J Cancer. 1604;125:2009.
   Google Scholar
• Janda E, Litos G, Grunert S, et al. Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Oncogene. 2002;21:5148.
   PubMed Web of Science ®Google Scholar
• Cho KB, Cho MK, Lee WY, et al. Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells. Cancer Lett. 2010;293:230.
   PubMed Web of Science ®Google Scholar
• Pan W, Xi QS, Xia SL, et al. Cloning and characterization of fup1, a gene highly expressed in hepatocellular carcinoma. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2001;33:173.
   Google Scholar
• Pan W, Zhang Q, Xi QS, et al. FUP1, a gene associated with hepatocellular carcinoma, stimulates NIH3T3 cell proliferation and tumor formation in nude mice. Biochem Biophys Res Commun. 2001;286:1033.
   PubMed Web of Science ®Google Scholar
• Fan C, Miao Y, Zhang X, et al. Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer. BMC Cancer. 2014;14:704.
   PubMed Web of Science ®Google Scholar
• Fang LZ, Zhang JQ, Liu L, et al. Silencing of Btbd7 inhibited epithelial-mesenchymal transition and chemoresistance in CD133(+) lung carcinoma A549 cells. Oncol Res. 2017;25:819.
   PubMed Web of Science ®Google Scholar
• Luo FY, Liu ZH, Hu QH, et al. Association of BTBD7 with metastasis and poor prognosis in non-small-cell lung cancer patients. J Cancer. 2015;6:477.
   PubMed Web of Science ®Google Scholar